(Q54793849)

English

Conversion of azathioprine into mercaptopurine and mercaptoimidazole derivatives in vitro and during immunosuppressive therapy.

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4867621

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/4867621

title

Conversion of azathioprine into mercaptopurine and mercaptoimidazole derivatives in vitro and during immunosuppressive therapy. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4867621

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/4867621

1 reference

1 reference

Chalmers AH

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4867621

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/4867621

Knight PR

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4867621

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/4867621

Atkinson MR

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4867621

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/4867621

publication date

1 December 1967

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4867621

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/4867621

published in

The Australian Journal of Experimental Biology and Medical Science

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4867621

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/4867621

volume

45

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4867621

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/4867621

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4867621

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/4867621

page(s)

681-691

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4867621

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/4867621

Identifiers

DOI

10.1038/ICB.1967.68

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4867621

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/4867621

Fatcat ID

release_ylz2v6kekvagfgrkwlveykgqoe

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/ylz2v6kekvagfgrkwlveykgqoe

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

4867621

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4867621

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/4867621

(Q54793849)

Conversion of azathioprine into mercaptopurine and mercaptoimidazole derivatives in vitro and during immunosuppressive therapy.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)